Drug Discovery Services Market Forecast, Trend Analysis & Competition Tracking - Global Review 2017 to 2026

Jan 2018| FMR011A| Fact Market Research

Report Highlights

In the past few decades, the time and cost of drug development have soared. Significant investment is being made to convert new compound into a drug, reflecting complexity of the process. With the technological advancements, drug discovery technology is also improving. New technologies and in-depth understanding of biology by pharmaceutical companies is also likely to reduce costs of new drugs. Also discovery of new drugs is driving the demand for specialized support and tools. This Fact.MR report analyzes the expansion of global drug discovery services market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.

Scope

The scope of Fact.MR’s report is to analyze the global drug discovery services market for the forecast period 2017-2026 and provide readers an unbiased and accurate analysis. Pharmaceutical companies and research institutes, in the global drug discovery services market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to drug discovery services.

Summary

The report commences with a brief information of the global drug discovery services market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global drug discovery services market.

Overview

The next section offers an overview of the global drug discovery services market. This comprises an introduction to the market, along with a standard definition of the product – drug discovery services. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global drug discovery services market, the report provides updates about market opportunities, which can benefit leading players of drug discovery services. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for drug discovery services market players to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of healthcare service providers, and cost structure are provided in this section.

Considering the wide scope of the global drug discovery services market, the report by Fact.MR offers in-depth analysis, segment-wise analysis and forecast. The global drug discovery services market is segmented on the basis of process, type, drug type, therapeutic area, and region. This segmentation also includes country-wise analysis considering all the key parameters of the global drug discovery services market.

The report’s last section comprises of the global drug discovery services market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global drug discovery services market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

  • Primary research
  • Secondary research
  • Trade research
  • Focused interviews
  • Social media analysis
  • Table 1 : Global Drug Discovery Services Market Value (US$ Mn), 2012-2017
  • Table 2 : Global Drug Discovery Services Market Value (US$ Mn), 2018-2026
  • Table 3 : Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • Table 4 : Global Target Selection Segment Value (US$ Mn), By Region 2012-2017
  • Table 5 : Global Target Selection Segment Value (US$ Mn), By Region 2018-2026
  • Table 6 : Global Target Selection Segment Market Share, By Region 2012-2017
  • Table 7 : Global Target Selection Segment Market Share, By Region 2018-2026
  • Table 8 : Global Target Selection Segment Y-o-Y, By Region 2017-2026
  • Table 9 : Global Target Validation Segment Value (US$ Mn), By Region 2012-2017
  • Table 10 : Global Target Validation Segment Value (US$ Mn), By Region 2018-2026
  • Table 11 : Global Target Validation Segment Market Share, By Region 2012-2017
  • Table 12 : Global Target Validation Segment Market Share, By Region 2018-2026
  • Table 13 : Global Target Validation Segment Y-o-Y, By Region 2017-2026
  • Table 14 : Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2012-2017
  • Table 15 : Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2018-2026
  • Table 16 : Global Hit-To-Lead Identification Segment Market Share, By Region 2012-2017
  • Table 17 : Global Hit-To-Lead Identification Segment Market Share, By Region 2018-2026
  • Table 18 : Global Hit-To-Lead Identification Segment Y-o-Y, By Region 2017-2026
  • Table 19 : Global Lead Optimization Segment Value (US$ Mn), By Region 2012-2017
  • Table 20 : Global Lead Optimization Segment Value (US$ Mn), By Region 2018-2026
  • Table 21 : Global Lead Optimization Segment Market Share, By Region 2012-2017
  • Table 22 : Global Lead Optimization Segment Market Share, By Region 2018-2026
  • Table 23 : Global Lead Optimization Segment Y-o-Y, By Region 2017-2026
  • Table 24 : Global Candidate Validation Segment Value (US$ Mn), By Region 2012-2017
  • Table 25 : Global Candidate Validation Segment Value (US$ Mn), By Region 2018-2026
  • Table 26 : Global Candidate Validation Segment Market Share, By Region 2012-2017
  • Table 27 : Global Candidate Validation Segment Market Share, By Region 2018-2026
  • Table 28 : Global Candidate Validation Segment Y-o-Y, By Region 2017-2026
  • Table 29 : Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2012-2017
  • Table 30 : Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2018-2026
  • Table 31 : Global Medicinal Chemistry Segment Market Share, By Region 2012-2017
  • Table 32 : Global Medicinal Chemistry Segment Market Share, By Region 2018-2026
  • Table 33 : Global Medicinal Chemistry Segment Y-o-Y, By Region 2017-2026
  • Table 34 : Global Biology Services Segment Value (US$ Mn), By Region 2012-2017
  • Table 35 : Global Biology Services Segment Value (US$ Mn), By Region 2018-2026
  • Table 36 : Global Biology Services Segment Market Share, By Region 2012-2017
  • Table 37 : Global Biology Services Segment Market Share, By Region 2018-2026
  • Table 38 : Global Biology Services Segment Y-o-Y, By Region 2017-2026
  • Table 39 : Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2012-2017
  • Table 40 : Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2018-2026
  • Table 41 : Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2012-2017
  • Table 42 : Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2018-2026
  • Table 43 : Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y, By Region 2017-2026
  • Table 44 : Global Small Molecules Segment Value (US$ Mn), By Region 2012-2017
  • Table 45 : Global Small Molecules Segment Value (US$ Mn), By Region 2018-2026
  • Table 46 : Global Small Molecules Segment Market Share, By Region 2012-2017
  • Table 47 : Global Small Molecules Segment Market Share, By Region 2018-2026
  • Table 48 : Global Small Molecules Segment Y-o-Y, By Region 2017-2026
  • Table 49 : Global Biologics Segment Value (US$ Mn), By Region 2012-2017
  • Table 50 : Global Biologics Segment Value (US$ Mn), By Region 2018-2026
  • Table 51 : Global Biologics Segment Market Share, By Region 2012-2017
  • Table 52 : Global Biologics Segment Market Share, By Region 2018-2026
  • Table 53 : Global Biologics Segment Y-o-Y, By Region 2017-2026
  • Table 54 : Global Oncology Segment Value (US$ Mn), By Region 2012-2017
  • Table 55 : Global Oncology Segment Value (US$ Mn), By Region 2018-2026
  • Table 56 : Global Oncology Segment Market Share, By Region 2012-2017
  • Table 57 : Global Oncology Segment Market Share, By Region 2018-2026
  • Table 58 : Global Oncology Segment Y-o-Y, By Region 2017-2026
  • Table 59 : Global Neurology Segment Value (US$ Mn), By Region 2012-2017
  • Table 60 : Global Neurology Segment Value (US$ Mn), By Region 2018-2026
  • Table 61 : Global Neurology Segment Market Share, By Region 2012-2017
  • Table 62 : Global Neurology Segment Market Share, By Region 2018-2026
  • Table 63 : Global Neurology Segment Y-o-Y, By Region 2017-2026
  • Table 64 : Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2012-2017
  • Table 65 : Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2018-2026
  • Table 66 : Global Cardiovascular Diseases Segment Market Share, By Region 2012-2017
  • Table 67 : Global Cardiovascular Diseases Segment Market Share, By Region 2018-2026
  • Table 68 : Global Cardiovascular Diseases Segment Y-o-Y, By Region 2017-2026
  • Table 69 : Global Respiratory Diseases Segment Value (US$ Mn), By Region 2012-2017
  • Table 70 : Global Respiratory Diseases Segment Value (US$ Mn), By Region 2018-2026
  • Table 71 : Global Respiratory Diseases Segment Market Share, By Region 2012-2017
  • Table 72 : Global Respiratory Diseases Segment Market Share, By Region 2018-2026
  • Table 73 : Global Respiratory Diseases Segment Y-o-Y, By Region 2017-2026
  • Table 74 : Global Diabetes Segment Value (US$ Mn), By Region 2012-2017
  • Table 75 : Global Diabetes Segment Value (US$ Mn), By Region 2018-2026
  • Table 76 : Global Diabetes Segment Market Share, By Region 2012-2017
  • Table 77 : Global Diabetes Segment Market Share, By Region 2018-2026
  • Table 78 : Global Diabetes Segment Y-o-Y, By Region 2017-2026
  • Table 79 : Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2012-2017
  • Table 80 : Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2018-2026
  • Table 81 : Global Other Therapeutic Areas Segment Market Share, By Region 2012-2017
  • Table 82 : Global Other Therapeutic Areas Segment Market Share, By Region 2018-2026
  • Table 83 : Global Other Therapeutic Areas Segment Y-o-Y, By Region 2017-2026
  • Table 84 : North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
  • Table 85 : North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 86 : North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 87 : North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 88 : North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 89 : North America Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Table 90 : North America Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Table 91 : North America Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Table 92 : North America Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Table 93 : North America Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Table 94 : North America Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Table 95 : North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Table 96 : North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Table 97 : North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Table 98 : North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Table 99 : Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
  • Table 100 : Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 101 : Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 102 : Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 103 : Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 104 : Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Table 105 : Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Table 106 : Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Table 107 : Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Table 108 : Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Table 109 : Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Table 110 : Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Table 111 : Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Table 112 : Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Table 113 : Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Table 114 : Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
  • Table 115 : Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 116 : Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 117 : Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 118 : Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 119 : Europe Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Table 120 : Europe Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Table 121 : Europe Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Table 122 : Europe Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Table 123 : Europe Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Table 124 : Europe Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Table 125 : Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Table 126 : Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Table 127 : Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Table 128 : Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Table 129 : Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
  • Table 130 : Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 131 : Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 132 : Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 133 : Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 134 : Japan Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Table 135 : Japan Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Table 136 : Japan Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Table 137 : Japan Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Table 138 : Japan Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Table 139 : Japan Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Table 140 : Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Table 141 : Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Table 142 : Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Table 143 : Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Table 144 : APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
  • Table 145 : APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 146 : APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 147 : APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 148 : APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 149 : APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Table 150 : APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Table 151 : APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Table 152 : APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Table 153 : APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Table 154 : APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Table 155 : APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Table 156 : APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Table 157 : APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Table 158 : APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Table 159 : MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
  • Table 160 : MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • Table 161 : MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • Table 162 : MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • Table 163 : MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • Table 164 : MEA Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Table 165 : MEA Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Table 166 : MEA Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Table 167 : MEA Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Table 168 : MEA Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Table 169 : MEA Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Table 170 : MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Table 171 : MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Table 172 : MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Table 173 : MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Figure 1 : Global Drug Discovery Services Market Value (US$ Mn), 2012-2017
  • Figure 2 : Global Drug Discovery Services Market Value (US$ Mn) Forecast, 2018-2026
  • Figure 3 : Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • Figure 4 : Global Target Selection Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 5 : Global Target Selection Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 6 : Global Target Selection Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 7 : Global Target Validation Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 8 : Global Target Validation Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 9 : Global Target Validation Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 10 : Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 11 : Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 12 : Global Hit-To-Lead Identification Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 13 : Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 14 : Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 15 : Global Lead Optimization Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 16 : Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 17 : Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 18 : Global Candidate Validation Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 19 : Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 20 : Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 21 : Global Medicinal Chemistry Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 22 : Global Biology Services Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 23 : Global Biology Services Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 24 : Global Biology Services Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 25 : Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 26 : Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 27 : Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 28 : Global Small Molecules Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 29 : Global Small Molecules Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 30 : Global Small Molecules Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 31 : Global Biologics Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 32 : Global Biologics Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 33 : Global Biologics Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 34 : Global Oncology Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 35 : Global Oncology Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 36 : Global Oncology Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 37 : Global Neurology Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 38 : Global Neurology Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 39 : Global Neurology Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 40 : Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 41 : Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 42 : Global Cardiovascular Diseases Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 43 : Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 44 : Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 45 : Global Respiratory Diseases Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 46 : Global Diabetes Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 47 : Global Diabetes Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 48 : Global Diabetes Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 49 : Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2012-2017
  • Figure 50 : Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2018-2026
  • Figure 51 : Global Other Therapeutic Areas Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • Figure 52 : North America Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Figure 53 : North America Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Figure 54 : North America Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Figure 55 : North America Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Figure 56 : North America Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Figure 57 : North America Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Figure 58 : North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Figure 59 : North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Figure 60 : North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Figure 61 : North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Figure 62 : Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Figure 63 : Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Figure 64 : Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Figure 65 : Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Figure 66 : Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Figure 67 : Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Figure 68 : Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Figure 69 : Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Figure 70 : Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Figure 71 : Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Figure 72 : Europe Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Figure 73 : Europe Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Figure 74 : Europe Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Figure 75 : Europe Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Figure 76 : Europe Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Figure 77 : Europe Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Figure 78 : Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Figure 79 : Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Figure 80 : Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Figure 81 : Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Figure 82 : Japan Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Figure 83 : Japan Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Figure 84 : Japan Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Figure 85 : Japan Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Figure 86 : Japan Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Figure 87 : Japan Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Figure 88 : Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Figure 89 : Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Figure 90 : Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Figure 91 : Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Figure 92 : APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Figure 93 : APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Figure 94 : APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Figure 95 : APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Figure 96 : APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Figure 97 : APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Figure 98 : APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Figure 99 : APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Figure 100 : APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Figure 101 : APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026
  • Figure 102 : MEA Drug Discovery Services Market Value (US$ Mn), By Country 2012-2017
  • Figure 103 : MEA Drug Discovery Services Market Value (US$ Mn), By Country 2018-2026
  • Figure 104 : MEA Drug Discovery Services Market Value (US$ Mn), By Process 2012-2017
  • Figure 105 : MEA Drug Discovery Services Market Value (US$ Mn), By Process 2018-2026
  • Figure 106 : MEA Drug Discovery Services Market Value (US$ Mn), By Type 2012-2017
  • Figure 107 : MEA Drug Discovery Services Market Value (US$ Mn), By Type 2018-2026
  • Figure 108 : MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2012-2017
  • Figure 109 : MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2018-2026
  • Figure 110 : MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2012-2017
  • Figure 111 : MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2018-2026

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

When do I get the report?
Most reports are fulfilled immediately. In some cases, it could take up to 24 hours.

In what format does this report get delivered to me?
We will send you an email with login credentials to access the report. You will also be able to download the pdf.

What are the free reports included in my purchase?
They consist of a collection of current reports from various partner publishers scanning multiple industries.

What is the difference between BCC Research and BCC Publishing?
BCC Research curates thousands of reports from different sources and provides access to this content to our clients. BCC Publishing is the publication arm of BCC Research (one of several publishers in our portal).

What reports do I get 'discounts' on with my purchase?
All reports. BCC Publishing reports will be available for a 50% discount. All other partner publishers are also available at deeply discounted rates.

Where are you located?
Wellesley Massachusetts, just outside of Boston, Massachusetts, USA.

How long has BCC Research been around?
We are approaching our 50 year anniversary in 2021!

What if I want you to invoice me for payment via Purchase Order?
Simply choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

What if I have a question about your reports?
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times, and included in every purchase, to help our customers find the research they need-when they need it.

Can I share this report with my team?
Absolutely yes, with the purchase of additional user licenses.

Can I use your research in my presentation?
Absolutely yes, so long as the publisher is properly cited.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report